Novo Nordisk Obesity Drugs Sales Slow – Compounders Still Selling illegally
August 6, 2025 Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of U.S. tariffs, coupled with continued competition from compounded drugs sold illegally. Novo Nordisk said sales of medications such as Ozempic – which mimic the GLP-1 gut hormone that regulates blood sugar levels and […]
Novo Nordisk Obesity Drugs Sales Slow – Compounders Still Selling illegally Read More »